NO2718725T3 - - Google Patents

Info

Publication number
NO2718725T3
NO2718725T3 NO12728976A NO12728976A NO2718725T3 NO 2718725 T3 NO2718725 T3 NO 2718725T3 NO 12728976 A NO12728976 A NO 12728976A NO 12728976 A NO12728976 A NO 12728976A NO 2718725 T3 NO2718725 T3 NO 2718725T3
Authority
NO
Norway
Application number
NO12728976A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44652046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2718725(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2718725T3 publication Critical patent/NO2718725T3/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442Chitinase (3.2.1.14)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08Sphingolipids
    • G01N2405/10Glycosphingolipids, e.g. cerebrosides, gangliosides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
NO12728976A 2011-06-06 2012-06-06 NO2718725T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11004597A EP2533051A1 (en) 2011-06-06 2011-06-06 Method for the diagnosis of Gaucher's disease
EP12728976.7A EP2718725B1 (en) 2011-06-06 2012-06-06 Method for the diagnosis of gaucher's disease
PCT/EP2012/002409 WO2012167925A1 (en) 2011-06-06 2012-06-06 Method for the diagnosis of gaucher's disease

Publications (1)

Publication Number Publication Date
NO2718725T3 true NO2718725T3 (pl) 2018-05-12

Family

ID=44652046

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12728976A NO2718725T3 (pl) 2011-06-06 2012-06-06

Country Status (15)

Country Link
US (3) US10859580B2 (pl)
EP (4) EP2533051A1 (pl)
JP (2) JP6120832B2 (pl)
CN (1) CN103582818B (pl)
AU (2) AU2012266768B2 (pl)
BR (1) BR112013031431B1 (pl)
CA (1) CA2837609C (pl)
DK (2) DK3318881T3 (pl)
ES (2) ES2659753T3 (pl)
IL (2) IL229607B (pl)
NO (1) NO2718725T3 (pl)
PL (2) PL3318881T3 (pl)
PT (2) PT3318881T (pl)
RU (1) RU2666952C2 (pl)
WO (1) WO2012167925A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014090404A1 (en) * 2012-12-11 2014-06-19 Centogene Ag Method for the diagnosis of metachromatic leukodystrophy
EP3105588A1 (en) * 2014-02-11 2016-12-21 Yeda Research and Development Co., Ltd. Marker of neuropathic gaucher's disease and methods of use thereof
CN105463085A (zh) * 2015-12-11 2016-04-06 上海新培晶医学检验所有限公司 一种检测戈谢病gba基因突变的试剂盒及其检测方法
EP3264092A1 (en) * 2016-07-01 2018-01-03 Centogene AG Use of lyso-gb1 as druggable target
RU2629626C1 (ru) * 2016-10-05 2017-08-30 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ оценки эффективности лечения болезни Гоше у детей
WO2023232942A1 (en) * 2022-06-01 2023-12-07 Universiteit Antwerpen Method for detecting lysosomal storage disease biomarkers and kits for performing the method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236838A (en) 1988-12-23 1993-08-17 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
UA63743A (en) * 2003-06-09 2004-01-15 Kyiv P Shupyk Medical Academy Method for diagnosing gaucher disease
EP1528056A1 (en) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
KR20080033242A (ko) 2005-06-08 2008-04-16 아미쿠스 세라퓨틱스, 인코포레이티드 리소좀 효소를 코딩하는 유전자의 돌연변이와 관련있는cns 질환의 치료 방법
KR101402554B1 (ko) * 2006-06-23 2014-06-19 아미쿠스 세라퓨틱스, 인코포레이티드 β-글루코세레브로시다제의 활성 증진에 의한 신경계 장애 치료 방법
MX2009011055A (es) 2007-04-13 2010-01-13 Amicus Therapeutics Inc Tratamiento de la enfermedad de gaucher con chaperonas farmacologicas especificas y supervision del tratamiento utilizando marcadores sustitutos.
US9056101B2 (en) 2007-04-26 2015-06-16 Amicus Therapeutics, Inc. Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
ES2559859T3 (es) 2007-05-16 2016-02-16 The Brigham And Women's Hospital, Inc. Tratamiento de sinucleinopatías
AU2009314447A1 (en) * 2008-11-14 2010-05-20 Neuraltus Pharmaceuticals, Inc. Compositions and methods for the treatment of altered alpha-synuclein function

Also Published As

Publication number Publication date
IL260078B (en) 2020-10-29
US20140187439A1 (en) 2014-07-03
DK3318881T3 (da) 2020-09-28
PT3318881T (pt) 2020-09-16
ES2659753T3 (es) 2018-03-19
JP6120832B2 (ja) 2017-04-26
IL260078A (en) 2018-07-31
BR112013031431B1 (pt) 2023-02-07
BR112013031431A2 (pt) 2016-12-13
JP6514256B2 (ja) 2019-05-15
PT2718725T (pt) 2018-03-07
RU2018129872A (ru) 2019-03-15
CA2837609C (en) 2023-04-18
PL3318881T3 (pl) 2021-02-08
RU2018129872A3 (pl) 2021-11-08
US20220011321A1 (en) 2022-01-13
RU2013158667A (ru) 2015-07-20
PL2718725T3 (pl) 2018-06-29
DK2718725T3 (en) 2018-03-26
ES2820361T3 (es) 2021-04-20
AU2017232226B2 (en) 2019-12-19
IL229607B (en) 2018-07-31
JP2017161528A (ja) 2017-09-14
AU2012266768B2 (en) 2017-06-29
CN103582818A (zh) 2014-02-12
EP3742168A1 (en) 2020-11-25
EP2718725B1 (en) 2017-12-13
US11092609B2 (en) 2021-08-17
RU2666952C2 (ru) 2018-09-13
EP2718725A1 (en) 2014-04-16
EP3318881A1 (en) 2018-05-09
US10859580B2 (en) 2020-12-08
EP2533051A1 (en) 2012-12-12
CA2837609A1 (en) 2012-12-13
US20180259538A1 (en) 2018-09-13
AU2017232226A1 (en) 2017-10-12
WO2012167925A1 (en) 2012-12-13
IL229607A0 (en) 2014-01-30
EP3318881B1 (en) 2020-07-15
JP2014517308A (ja) 2014-07-17
CN103582818B (zh) 2018-06-05

Similar Documents

Publication Publication Date Title
BR112013022641A2 (pl)
AP3853A (pl)
BR112013031251A2 (pl)
BR112013024383A2 (pl)
BR112013023185A2 (pl)
BR112013022995A2 (pl)
BR112013017670A2 (pl)
BR112013023927A2 (pl)
BR112013027830A2 (pl)
BR112013024365A2 (pl)
BR112013028733A2 (pl)
AP2016009466A0 (pl)
BR112013031556A2 (pl)
BR112013032380A2 (pl)
BR112013032377A2 (pl)
BR112013032366A2 (pl)
BR112013018949A2 (pl)
BR112013027761A2 (pl)
BR112013021637A2 (pl)
BR112013027836A2 (pl)
BR112013023266A2 (pl)
BR112013032392A2 (pl)
BR112013017878A2 (pl)
BR112013027871A2 (pl)
BR112013032394A2 (pl)